Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anita D'Souza, MD
Froedtert Hospital & the Medical College of Wisconsin
Principal Investigator - Jeffrey Zonder, MD
Barbara Ann Karmanos Cancer Institute Wertz Clinic
Principal Investigator - Michael Rosenzweig, MD
City of Hope National Medical Center
Principal Investigator - Vaishali Sanchorawala, MD
Boston Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope National Medical Center
Duarte, California, United States
Michael Rosenzweig, MDRecruiting - Boston Medical Center
Boston, Massachusetts, United States
Vaishali Sanchorawala, MDRecruiting - Barbara Ann Karmanos Cancer Institute Wertz Clinic
Detroit, Michigan, United States
Jeffrey Zonder, MDRecruiting - Froedtert Hospital & the Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Anita D'Souza, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Apr 2021
- Primary completion
- 30 Sept 2024
- Completion
- 31 Dec 2024
- Last update posted
- 17 Jan 2023
- Registered enrollment
- 60
- Registry id
- NCT04316442
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.